Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study

• Päätekijät: Takafumi Yuki, MD, PhD (Tekijä), Shunji Ishihara, MD, PhD (Tekijä), Kazuo Yashima, MD, PhD (Tekijä), Koichiro Kawaguchi, MD, PhD (Tekijä), Hirofumi Fujishiro, MD, PhD (Tekijä), Youichi Miyaoka, MD, PhD (Tekijä), Mika Yuki, MD, PhD (Tekijä), Yoshinori Kushiyama, MD, PhD (Tekijä), Akiko Yasugi, MD, PhD (Tekijä), Michiko Shabana, MD, PhD (Tekijä), Koichirou Furuta, MD, PhD (Tekijä), Kiwamu Tanaka, MD, PhD (Tekijä), Masaharu Koda, MD, PhD (Tekijä), Tetsuro Hamamoto, MD, PhD (Tekijä), Yuichiro Sasaki, MD, PhD (Tekijä), Hisao Tanaka, MD, PhD (Tekijä), Teiji Yoshimura, MD (Tekijä), Yoshikazu Murawaki, MD, PhD (Tekijä), Hajime Isomoto, MD, PhD (Tekijä), Yoshikazu Kinoshita, MD, PhD (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2017-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Although antithrombotic agents are widely used for cardiac and cerebrovascular disease prevention, they increase the risk of gastrointestinal (GI) bleeding. Objective: To examine GI bleeding risk in association with an esophagogastroduodenoscopy (EGD) biopsy performed in patients without...